ALLMedicine™ Cataracts Center

Mar 25th, 2023 - Persistent visual impairments after congenital blindness due to dense bilateral cataracts have been attributed to altered visual cortex development within a sensitive period. Occipital alpha (8-14 Hz) oscillations were found to be reduced after co...

Mar 25th, 2023 - To compare the postoperative visual outcomes and quality of vision obtained with two types of diffractive trifocal intraocular lenses (IOLs) in patients with high-myopic cataracts. Prospective, multi-center, randomized controlled trial. Patients w...

Mar 25th, 2023 - To investigate the association of social determinants of health (SDOH) factors and cataract-related outcomes disparities. Cross-sectional, with a nationally representative sample. We used publicly available data from the 2008, 2016, and 2017 Natio...

Mar 25th, 2023 - BACKGROUND Lowe syndrome, also known as oculocerebrorenal syndrome, is a rare genetic condition caused by an X-linked mutation of the OCRL1 gene, with an estimated prevalence in the general population of approximately 1 in 500 000. It is a multisy...

Mar 23rd, 2023 - Automatic recognition of surgical activities from intraoperative surgical videos is crucial for developing intelligent support systems for computer-assisted interventions. Current state-of-the-art recognition methods are based on deep learning whe...

Feb 23rd, 2016 - Screening for Impaired Visual Acuity in Older Adults: Clinical Summary Population Adults 65 years or older who do not present with vision problems Recommendation No recommendation. Grade: I (insufficient evidence) Risk Assessment Older a...

Jul 8th, 2009 - Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for visual impairment. The USPSTF reviewed evidence published since its last review on screening adults 65 years or older in the primary care set...

Many people turn to dietary supplements to try to prevent or slow the progression of eye conditions such as age-related macular degeneration (AMD), glaucoma, or cataracts. Here are 5 things you should know if you are considering taking dietary sup...

Mar 9th, 2023 - Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab externo approach. Adverse events and intraocular pressu...

Mar 7th, 2023 - Cataracts are a common condition in adults over 40 years of age, and surgical replacement of the cataractous lens with an intraocular lens (IOL) remains an effective way to restore vision to cataract patients.The objective of the study is to evalu...

Feb 22nd, 2023 - This is a prospective, multicenter, post-market observational study at approximately 5 sites in the United States. All clinical sites will have Institutional Review Board (IRB) approval prior to recruiting potential subjects. All subjects who meet...

Feb 21st, 2023 - Cataracts and vitreo-retinal conditions are frequently associated, such as epimacular membranes, vitreomacular tractions, macular holes, or even macular edema. Cataract is also a frequent complication of posterior vitrectomy. Surgical treatment fo...

Feb 16th, 2023 - Objective: This project, Clinical and Molecular Studies in Families with Inherited Eye Disease will study inherited eye diseases, both Mendelian and complex age related inherited eye diseases, in families of many nationalities and ethnic backgroun...

Aug 27th, 2022 - Baseline ocular conditions not related to the cornea have little effect on treatment-emergent adverse effects (TEAEs) that may arise with belantamab mafodotin-blmf (Blenrep) in patients with relapsed/refractory multiple myeloma, according to a pos...

Aug 26th, 2022 - Treatment with daratumumab (Darzalex) plus lenalidomide (Revlimid) and dexamethasone for at least 18 months led to deep clinical responses in patients with treatment-naïve multiple myeloma who were transplant ineligible, according to post hoc anal...

Aug 18th, 2022 - The addition of belantamab mafodotin-blmf (Blenrep) to lenalidomide (Revlimid) and dexamethasone generated responses with acceptable safety in patients with newly diagnosed multiple myeloma who were ineligible to undergo autologous stem cell trans...

Aug 3rd, 2022 - Monkeypox Cases Escalate, but Clinicians Don't Need to Worry, According to Experts US clinicians do not need to start worrying about monkeypox just yet, despite global fatalities reported this past week, according to public health experts. Cases r...

Aug 2nd, 2022 - While tracking the extent of physician practice acquisition by private equity firms may be difficult, new research highlights what specialties and US regions are most affected by such purchases. The study, supported by the National Institute for H...